Institute for Vision Research and Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin.
Retina. 2024 Oct 1;44(10):1766-1776. doi: 10.1097/IAE.0000000000004176.
To describe an ophthalmoscopic sign, termed a meniscus micropyon, and its possible association with proliferative vitreoretinopathy/epiretinal membrane (ERM) formation after retinal surgery with gas tamponade.
Patients with intravitreal gas were examined postoperatively by one of six vitreoretinal surgeons from four institutions. A micropyon was defined as a white-yellow, solid-appearing consolidation along the meniscus (i.e., the fluid-gas interface).
A micropyon was visualized and photographed in 49 patients who received intravitreal gas. Preoperatively, retinal breaks were present in all 49 eyes and rhegmatogenous retinal detachment in 45 (92%). Postoperatively, 39 eyes (80%) developed epiretinal proliferation: 16 eyes (33%) developed recurrent rhegmatogenous retinal detachment from proliferative vitreoretinopathy, 6 eyes (12%) re-detached without frank proliferative vitreoretinopathy, 9 eyes (18%) developed postoperative ERM/worsening, and 8 eyes (16%) had postoperative ERM but no preoperative optical coherence tomography to determine if the postoperative ERM was new or worsening. The single-operation anatomical success in eyes with a micropyon was 51%, which was lower than that of a contemporaneous rhegmatogenous retinal detachment control group (91%) in which no micropyon was detected. In two patients, micropyons were biopsied during pars plana vitrectomy and examined histopathologically; they consist predominantly of white blood cells.
The meniscus micropyon is an ophthalmoscopic sign that can occur after retinal surgery with gas tamponade. Features that distinguish a micropyon from postvitrectomy fibrin/fibrinoid syndrome include delayed appearance, hyperautofluorescence, absence of translucent strands or sheets in the anterior chamber or vitreous cavity, and the histopathologic identification of white blood cells. A clinically detectable micropyon may be a biomarker of proliferative vitreoretinopathy/ERM formation.
描述一种称为新月形微息肉的眼底征象及其与视网膜手术后气体填充眼压治疗后发生的增生性玻璃体视网膜病变/视网膜前膜(ERM)形成的可能关联。
四家机构的六名玻璃体视网膜外科医生对接受眼内气体填充的患者进行术后检查。微息肉被定义为沿新月形(即液体-气体界面)出现的白色-黄色、实体样凝固物。
在接受眼内气体填充的 49 名患者中,观察到并拍摄到了微息肉。术前,所有 49 只眼均存在视网膜裂孔,45 只眼(92%)存在孔源性视网膜脱离。术后,39 只眼(80%)发生了视网膜前膜增殖:16 只眼(33%)因增生性玻璃体视网膜病变发生了复发性孔源性视网膜脱离,6 只眼(12%)再次脱离但无明显增生性玻璃体视网膜病变,9 只眼(18%)发生了术后 ERM/加重,8 只眼(16%)发生了术后 ERM,但没有术前光学相干断层扫描来确定术后 ERM 是新出现的还是加重的。有微息肉的单眼手术解剖成功率为 51%,低于同期未检测到微息肉的孔源性视网膜脱离对照组(91%)。在两名患者中,微息肉在经睫状体平坦部玻璃体切割术中被活检,并进行了组织病理学检查;它们主要由白细胞组成。
新月形微息肉是视网膜手术后气体填充眼压治疗后出现的眼底征象。微息肉与玻璃体切割术后纤维蛋白/纤维蛋白样综合征的区别特征包括出现时间延迟、高自发荧光、前房或玻璃体腔无半透明条索或薄片,以及白细胞的组织病理学鉴定。临床上可检测到的微息肉可能是增生性玻璃体视网膜病变/ERM 形成的生物标志物。